- $237.48bn
- $280.79bn
- $36.75bn
Brief: UK's MHRA Completes Review Of Avacopan Vifor
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
UK regulator suspends Amgen's Tavneos for new patients over unreliable data
Trump administration announces drug pricing deals with CSL, Astellas and others (updated)
Trump administration to announce drug pricing deals
UK Stocks-Factors to watch on August 27 (updated)
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial (updated)
Brief: Amgen Says Tezspire Safety Profile Consistent With Approved Indications
AstraZeneca's asthma drug Tezspire meets all goals in late-stage esophagitis trial
U.S. RESEARCH ROUNDUP-Amgen, Analog Devices, Moderna
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing
GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech (updated)
Factbox: Global drugmakers invest billions to boost US presence
Factbox: Global drugmakers invest billions to boost US presence
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
U.S. STOCKS ON THE MOVE-Walt Disney, Alphabet, Kraft Heinz
U.S. STOCKS ON THE MOVE-Wynn Resorts, Griffon, Kratos Defense, Amgen
Amgen jolts to record-high after hiking FY forecasts, Q2 results beat